SensiCardiac was developed to detect all major structural cardiac defects (valvular and congenital).
The guidelines of the American Heart Association and American College of Cardiology (AHA/ACC) was used in the development of SensiCardiac for echocardiography recommendations:
- Echocardiography is recommended for asymptomatic patients with diastolic murmurs, continuous murmurs, holosystolic murmurs, late systolic murmurs, murmurs associated with ejection clicks, or murmurs that radiate to the neck or back.
- Echocardiography is recommended for patients with heart murmurs and symptoms or signs of heart failure, myocardial ischemia/infarction, syncope, thromboembolism, infective endocarditis, or other clinical evidence of structural heart disease.
- Echocardiography is recommended for asymptomatic patients who have grade 3 or louder mid-peaking systolic murmurs.
- Echocardiography can be useful for the evaluation of asymptomatic patients with murmurs associated with other abnormal cardiac physical findings or murmurs associated with an abnormal electrocardiogram (ECG) or chest X-ray.
- Echocardiography can be useful for patients whose symptoms and/or signs are likely non-cardiac in origin, but in whom a cardiac basis cannot be excluded by standard evaluation.
- Echocardiography is not recommended for patients who have a grade 2 or softer midsystolic murmur identified as innocent or functional by an experienced observer.
SensiCardiac was trained and tested using a database of the following cardiac pathologies:
- Mitral Stenosis and Regurgitation
- Mitral Valve Prolapse
- Aortic Stenosis and Regurgitation
- Tricuspid Valve Stenosis and Regurgitation
- Pulmonary Valve Stenosis and Regurgitation
- Bicuspid aortic valve (BAV)
- Subvalvular aortic stenosis (SAS)
- Atrial septal defect (ASD)
- Ventricular septal defect (VSD)
- Patent ductus arteriosus (PDA)
- Coarctation of the aorta
- Pulmonary valve stenosis (PVS)
- Ebstein’s anomaly
- Tetralogy of Fallot (TOF)
- Transposition of the great vessels (TGV)